Ci ALLOZYNE INC
Allozyne was a clinical stage biotechnology company headquartered in Seattle's biotech and high tech innovation corridor. Allozyne was founded in 2005 by California Institute of Technology researchers, and was incubated by Accelerator Corporation. Its lead product candidate, AZ01, is a long acting interferon beta for the treatment of the relapsing remitting form of multiple sclerosis, a chronic degenerative disease characterized by demyelination of nerve fibers leading to severe nerve damage and increasing disability. Multiple sclerosis is estimated to affect 400,000 individuals in the US alone and 2.5 million worldwide. AZ01 is currently undergoing Phase I clinical trials in the US. Preclinical data indicates that AZ01 has the potential to be dosed once monthly compared to the current standard of care dosed anywhere from once daily to once per week.
Source: Wikipedia
LiggéeyBiotechnology
Kër bu magSeattle, WA
Sos nañu ko2005
Melokaan yoonC Corporation
NekkinDox
Nimero yu am solo
Duggal ngir gis lim yu am solo yi
Njëg, ñoor bu set ak limu liggéeykat yu ALLOZYNE INC ci at yi, ak fi ñu jële.
Dugg Sos ab kont ak sa imeelAmul fay
Bu nga wéyee, nangu nga Déggoo jëfandikukat bi, Politig sutura bi ak Politig cookies yi yu Heelky.
Xibaaru yoon
| Turu yoon | ALLOZYNE INC |
|---|---|
| Melokaan yoon | C Corporation |
| SEC CIK | 1345630Xool ci SEC EDGAR ↗ |
| Adresu bindu | Seattle, WA |
| Nekkin | Dox |
Cosaan: SEC EDGAR · yeesal Nov. 14, 2026
Jokkoo & lëkkalekaay
Barab
Seattle, WA
Ndax sa sosiete la?
Jël xët bii bu amul fay ngir yokk sa logo, yëf, nataal ak liggéey, te tontu xool.
Jël xët biiBokku ci Heelky ngir jokkoo, jëfandikoo ak yokkte
Sos kont bu amul fay ngir yónnee nit, jot liggéey te yónnee misiyooŋ.
Bokku léegi — amul fay